aliskiren vs potassium citrate
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of aliskiren and potassium citrate. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
7.3 Renin-Angiotensin-Aldosterone System Inhibitors Drugs that inhibit the renin-angiotensin-aldosterone system (RAAS) including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), spironolactone, eplerenone, or aliskiren produce potassium retention by inhibiting aldosterone production.
Tekturna
Urocit-K
Tekturna is a medicine used to treat high blood pressure. It helps lower blood pressure, which can reduce the risk of strokes and heart attacks.
Potassium citrate is a medicine that helps manage kidney problems. It can help prevent kidney stones and balance the acid levels in your urine.
Tekturna is used to treat high blood pressure in adults and children who weigh at least 110 pounds and are 6 years or older. Lowering your blood pressure helps prevent strokes and heart attacks. It is important to manage high blood pressure with a healthy lifestyle too.
This medicine is used to manage renal tubular acidosis (RTA) with calcium stones. It also treats hypocitraturic calcium oxalate nephrolithiasis, which is a condition that causes calcium oxalate kidney stones. Potassium citrate can also help with uric acid kidney stones, whether or not you also have calcium stones.
Tekturna works by blocking a substance in your body called renin. Renin helps to control your blood pressure. By blocking renin, Tekturna helps to lower your blood pressure.
Potassium citrate works by increasing the amount of citrate in your urine. This makes your urine less acidic. Less acidic urine helps prevent kidney stones from forming.
- • Diarrhea
- • Abdominal discomfort
- • Vomiting
- • Diarrhea
- • Loose bowel movements
- • Nausea
- Asthenia 367
- Fall 356
- Nausea 336
- Dyspnoea 315
- Headache 301
- Fatigue 346
- Nausea 320
- Diarrhoea 310
- Pain 300
- Nephrolithiasis 270
Tekturna can harm your unborn baby, even causing death. If you become pregnant, stop taking Tekturna right away and tell your doctor.
This medicine can cause high potassium levels in your blood, which can be dangerous. You should not take this medicine if you have kidney failure, uncontrolled diabetes, or other conditions that make it hard for your body to get rid of potassium. If you have severe vomiting, stomach pain, or bleeding, stop taking this medicine and contact your doctor immediately.
Tekturna can cause serious harm or death to an unborn baby. If you are pregnant or plan to become pregnant, talk to your doctor about other blood pressure medicines. Breastfeeding is not recommended while taking Tekturna.
It is not known if this medicine will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if this medicine passes into breast milk, so talk to your doctor if you are breastfeeding.
How to Read This aliskiren vs potassium citrate Comparison
aliskiren is classified in the Direct Renin Inhibitor drug class, while potassium citrate sits within the Urinary Alkalinizer class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aliskiren has 1,675 submissions while potassium citrate has 1,546. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to aliskiren blocks a hormone that helps the body get rid of potassium, which can lead to a buildup when combined with potassium citrate.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for aliskiren or potassium citrate.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.